These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mitochondrial function as an emerging 'target of interest' for cancer treatment. Sausville EA Curr Opin Investig Drugs; 2009 Jun; 10(6):523-5. PubMed ID: 19513940 [No Abstract] [Full Text] [Related]
4. Subversion of the Bcl-2 life/death switch in cancer development and therapy. Adams JM; Huang DC; Strasser A; Willis S; Chen L; Wei A; van Delft M; Fletcher JI; Puthalakath H; Kuroda J; Michalak EM; Kelly PN; Bouillet P; Villunger A; O'Reilly L; Bath ML; Smith DP; Egle A; Harris AW; Hinds M; Colman P; Cory S Cold Spring Harb Symp Quant Biol; 2005; 70():469-77. PubMed ID: 16869785 [TBL] [Abstract][Full Text] [Related]
6. Breaking down tumor defenses. Hockenbery D Chem Biol; 2004 Apr; 11(4):417-8. PubMed ID: 15123233 [No Abstract] [Full Text] [Related]
7. Anticancer drug resistance and inhibition of apoptosis. Desoize B Anticancer Res; 1994; 14(6A):2291-4. PubMed ID: 7825961 [TBL] [Abstract][Full Text] [Related]
8. Bcl-2 family proteins as targets for anticancer drug design. Huang Z Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis research is yielding many potential drug targets. Nelson NJ J Natl Cancer Inst; 1997 Nov; 89(22):1660-1. PubMed ID: 9390531 [No Abstract] [Full Text] [Related]
10. [Progress in small-molecule inhibitors of Bcl-2 family proteins]. Tang Y; Zhang DY; Wu XM Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468 [TBL] [Abstract][Full Text] [Related]
11. [Role of the p53 and bcl-2 genes in apoptosis and drug resistance of tumors]. Luk'ianova NIu; Kulik GI; Chehun VF Vopr Onkol; 2000; 46(2):121-8. PubMed ID: 10853407 [No Abstract] [Full Text] [Related]
12. Apoptosis in the development and treatment of cancer. Gerl R; Vaux DL Carcinogenesis; 2005 Feb; 26(2):263-70. PubMed ID: 15375012 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis in leukemia: from molecular pathways to targeted therapies. Schimmer AD Best Pract Res Clin Haematol; 2008 Mar; 21(1):5-11. PubMed ID: 18342807 [TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondria emerges as therapeutic strategy. Garber K J Natl Cancer Inst; 2005 Dec; 97(24):1800-1. PubMed ID: 16368937 [No Abstract] [Full Text] [Related]
16. Targeting mitochondria for cancer therapy. Hockenbery DM Environ Mol Mutagen; 2010 Jun; 51(5):476-89. PubMed ID: 20213841 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis and cancer: when BAX is TRAILing away. Roth W; Reed JC Nat Med; 2002 Mar; 8(3):216-8. PubMed ID: 11875486 [No Abstract] [Full Text] [Related]
18. Novel apoptosis inducing agents in cancer therapy. Mita M; Tolcher AW Curr Probl Cancer; 2005; 29(1):8-32. PubMed ID: 15672328 [No Abstract] [Full Text] [Related]
20. The role of Bcl-2 family proteins in chronic lymphocytic leukaemia. Buggins AG; Pepper CJ Leuk Res; 2010 Jul; 34(7):837-42. PubMed ID: 20359747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]